4.1 Article

Bone Tissue Engineering Using Osteogenic Cells: From the Bench to the Clinical Application

期刊

TISSUE ENGINEERING PART C-METHODS
卷 28, 期 5, 页码 179-192

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tec.2022.0021

关键词

bone regeneration; scaffold; bone tissue; tissue engineering; osteogenic cell

向作者/读者索取更多资源

The review summarizes the latest studies and clinical trials related to bone tissue regeneration using osteogenic cells, biomaterials, and scaffolds. It highlights the importance of scaffolds in transporting cells and supporting the mineralization process, as well as the evaluation of their properties on bone regeneration. The review also emphasizes the key factors and mechanisms involved in bone homeostasis and the differentiation of osteoblast lineage.
The use of tissue engineering to restore and to build new bone tissue is under active research at present. The following review summarizes the latest studies and clinical trials related to the use of osteogenic cells, biomaterials, and scaffolds to regenerate bone defects in the human jaws. Bone tissue engineering (BTE) combined with scaffolds have provided a range of advantages not only to transport the target cells to their desired destination but also to support the early phases of the mineralization process. The mechanical, chemical, and physical properties of scaffolds have been evaluated as they affect the quantity of bone regeneration, particularly in the oral cavity. This review also highlighted the mechanisms underlying bone homeostasis, including the key transcription factors and signaling pathways responsible for regulating the differentiation of osteoblast lineage. Furthering understanding of the mechanisms of cellular signaling in skeletal remodeling with the use of mesenchymal stem cells and the proper scaffold properties are key-factors to enable the incorporation of new and effective treatment methods into clinical practice for bone tissue regeneration using BTE. Impact StatementThe use of mesenchymal stem cells able to differentiate in osteoblast lineage for bone tissue engineering (BTE) remains a major challenge. Viable cells and signaling pathways play an essential role in bone repair and regeneration of critical size defects. Recent advances in scaffolds and biological factors such as growth factors (e.g., cytokines and hormones) controlling the osteogenic signaling cascade are now becoming new players affecting the osteogenic potential of cells. Such techniques will significantly impact the maxillofacial bone tissue replacement, repair, and regeneration for patients without having to rely on donor banks or other surgical sites.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据